Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03465774 · ClinicalTrials.gov registry record
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
A clinical trial of Pleural Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 208
- Enrollment target
- 1
- Study location
NCT03465774 is a study of Pleural Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 208 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03465774, a study of Pleural Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to obtain preliminary data comparing indwelling pleural catheters (IPCs) versus IPCs plus doxycycline for pleurodesis as treatments for malignant pleural effusion (MPE). Indwelling pleural catheters (IPCs) are commonly used to treat pleural effusions (build-up of fluid in the lungs). Doxycycline is an antibiotic that is also used to treat pleural effusions. The goal of this clinical research study is to learn if adding doxycycline to the use of an IPC can lead to shorter treatment times with IPCs.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- DRUG Doxycycline
- DEVICE Indwelling Catheter
- PROCEDURE Quality-of-Life Assessment
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2028-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03465774
The ClinicalTrials.gov registry entry for NCT03465774 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleural Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Survey Administration is the first listed.
NCT03465774 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03465774 about?
NCT03465774 is a clinical study titled "Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions". This study is designed to obtain preliminary data comparing indwelling pleural catheters (IPCs) versus IPCs plus doxycycline for pleurodesis as treatments for malignant pleural effusion (MPE). Indwelling pleural catheters (IPCs) are commonly used to treat pleural effusions (build-up of fluid in the ...
What is the current status of trial NCT03465774?
This trial is currently recruiting. The enrollment target is 208 participants. The study started on 2018-03-08. Estimated completion is 2028-12-01.
What conditions does trial NCT03465774 study?
This clinical trial studies the following conditions: Pleural Neoplasm.
What interventions are being tested in trial NCT03465774?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Doxycycline (DRUG), Indwelling Catheter (DEVICE), Quality-of-Life Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT03465774?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03465774 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pleural Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.